Taniguchi, E <br/><br/>
PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma.  [electronic resource] 

 -  Oncogene  Nov 2008 
 - 6550-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2008.255  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Benzamides<br/>Cell Line, Tumor<br/>Cells, Cultured<br/>Genes, p16<br/>Humans<br/>Imatinib Mesylate<br/>Mice<br/>Mice, Knockout<br/>Muscle Neoplasms--drug therapy<br/>Piperazines--therapeutic use<br/>Protein Kinase Inhibitors--therapeutic use<br/>Pyrimidines--therapeutic use<br/>Receptor, Platelet-Derived Growth Factor alpha--antagonists & inhibitors<br/>Rhabdomyosarcoma, Alveolar--drug therapy<br/>Xenograft Model Antitumor Assays